Trademark Overview
On Friday, August 15, 2025, a trademark application was filed for GLYCOPHOS with the United States Patent and Trademark Office. The USPTO has given the GLYCOPHOS trademark a serial number of 99340806. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Friday, December 12, 2025. This trademark is owned by Fresenius Kabi AG. The GLYCOPHOS trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations, namely organic phosphate for treating nutritional conditions in the nature of medication used as a supplement in intravenous nutrition administered to both adults and children to meet their daily phosphate requirements; Nutritional supplement containing organic phosphate; Intravenous fluids containing organic phosphate used for rehydration, nutrition and the delivery of pharmaceutical preparations; Nutritional supplements containing sodium glycerophosphate for parenteral nutrition in adult and pediatric patients when oral or enteral nutrition is not possible, insufficient, or contraindicated; Pharmaceutical preparations, namely, intravenous fluids to correct hypophosphatemia in adult and pediatric patients when oral or enteral replacement is not possible, insufficient, or contraindicated.
